Jeff Hackman Email and Phone Number

As the CEO of Fennec Pharmaceuticals, I lead a specialty pharmaceutical company focused on the development and commercialization of PEDMARK® to reduce the risk of platinum-induced ototoxicity in pediatric and young adults. With over 25 years of experience in the bio-pharma industry, I have a proven track record of driving growth, launching products, and building high-performance teams in global and entrepreneurial settings.My core competencies include strategy, business development, fund raising, commercial operations, finance, and regulatory affairs. I have successfully led the acquisition, integration, and divestiture of several companies, as well as the negotiation and execution of multiple partnerships and licensing deals. I have also overseen the development and launch of several products in various therapeutic areas, such as oncology, hematology, immunology, and infectious diseases. My mission is to leverage my life sciences expertise and strategic vision to deliver value to patients, shareholders, and stakeholders.